← Back to Search

Physical Activity Promotion for Alzheimer's Disease in Adults With Down Syndrome

N/A
Waitlist Available
Led By Lauren Ptomey, PhD
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights

Study Summary

This trial is testing whether remotely delivered group exercise sessions can increase moderate to vigorous physical activity in adults with Down syndrome, compared to usual care control.

Eligible Conditions
  • Alzheimer's Disease
  • Down Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Moderate to Vigorous Physical Activity (MVPA)
Secondary outcome measures
Brain volume
Cardiovascular fitness
Cerebral blood flow
+7 more
Other outcome measures
Activities of daily living
Caregiver burden
Caregiver quality of life
+8 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Remote LowExperimental Treatment1 Intervention
Group II: Remote HighExperimental Treatment1 Intervention
Group III: Personal CoachExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Remote Low
2020
N/A
~90
Remote High
2020
N/A
~90
Personal Coach
2020
N/A
~90

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
460 Previous Clinical Trials
169,034 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,983 Total Patients Enrolled
Lauren Ptomey, PhDPrincipal InvestigatorUniversity of Kansas Medical Center

Media Library

Remote High Clinical Trial Eligibility Overview. Trial Name: NCT04048759 — N/A
Alzheimer's Disease Research Study Groups: Personal Coach, Remote Low, Remote High
Alzheimer's Disease Clinical Trial 2023: Remote High Highlights & Side Effects. Trial Name: NCT04048759 — N/A
Remote High 2023 Treatment Timeline for Medical Study. Trial Name: NCT04048759 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies left in this clinical trial for participants?

"The clinicaltrials.gov registry notes that this particular medical trial, which was initially launched in January of 2020 and last updated on November 29th 2022 is no longer open for recruitment. However, 1948 other trials are currently enrolling patients at the moment."

Answered by AI
~16 spots leftby Apr 2025